Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • 50th Volume Reprints
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow Jrheum on BlueSky
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study

Konstantinos Tselios, Dafna D. Gladman, Jiandong Su and Murray B. Urowitz
The Journal of Rheumatology March 2016, 43 (3) 552-558; DOI: https://doi.org/10.3899/jrheum.150779
Konstantinos Tselios
From the Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dafna D. Gladman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jiandong Su
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Murray B. Urowitz
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.urowitz{at}utoronto.ca
  • Article
  • Figures & Data
  • Info & Metrics
  • References
  • PDF
PreviousNext
Loading

Article Information

vol. 43 no. 3 552-558
DOI 
https://doi.org/10.3899/jrheum.150779
PubMed 
26773121

Published By 
The Journal of Rheumatology
Print ISSN 
0315-162X
Online ISSN 
1499-2752
History 
  • Accepted for publication November 24, 2015
  • Published online March 1, 2016.

Article Versions

  • Latest version (January 15, 2016 - 04:00).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2016

Author Information

  1. Konstantinos Tselios,
  2. Dafna D. Gladman,
  3. Jiandong Su and
  4. Murray B. Urowitz⇑
  1. From the Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network, Toronto, Ontario, Canada.
  2. K. Tselios, MD, PhD, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; D.D. Gladman, MD, FCRPC, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; J. Su, MB, BSc, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network; M.B. Urowitz, MD, FRCPC, Centre for Prognosis Studies in Rheumatic Diseases, University of Toronto Lupus Clinic, University Health Network.
  1. Address correspondence to Dr. M.B. Urowitz, University of Toronto Lupus Clinic, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital, 399 Bathurst St., 1E-410B, Toronto, Ontario M5T 2S8, Canada. E-mail: m.urowitz{at}utoronto.ca

Article usage

Article usage: January 2016 to December 2025

AbstractFullPdf
Jan 2016322075
Feb 2016112551
Mar 201672641134
Apr 20161871937
May 2016118827
Jun 2016622323
Jul 2016442219
Aug 20164679
Sep 2016591012
Oct 201676512
Nov 201643511
Dec 20168849
Jan 20173933
Feb 20175578
Mar 20175124
Apr 20174733
May 20176975
Jun 20175958
Jul 20172366
Aug 20172154
Sep 20174742
Oct 20173165
Nov 20173993
Dec 20174711
Jan 20183556
Feb 201860119
Mar 20185034
Apr 20186588
May 20183712
Jun 20184832
Jul 20183163
Aug 20182920
Sep 20185043
Oct 20183022
Nov 20182422
Dec 20182031
Jan 20193322
Feb 20192866
Mar 20192131
Apr 20193241
May 20193972
Jun 20193265
Jul 201924125
Aug 20196394
Sep 20192463
Oct 20192462
Nov 20193793
Dec 20195931
Jan 202025269
Feb 202093413
Mar 202045111
Apr 202024413
May 202044621
Jun 20203106
Jul 202092212
Aug 20205268
Sep 202072112
Oct 202041313
Nov 202081510
Dec 202063311
Jan 20212188
Feb 202116449
Mar 202124516
Apr 202161511
May 202166859
Jun 202183011
Jul 20214308
Aug 20215178
Sep 202143614
Oct 202162611
Nov 20215319
Dec 202143714
Jan 202273212
Feb 202210163
Mar 2022195210
Apr 202237277
May 202234012
Jun 202251913
Jul 20223234
Aug 20224369
Sep 202262715
Oct 20228276
Nov 202245313
Dec 202223031
Jan 202355715
Feb 20232283
Mar 202323710
Apr 202334611
May 202322117
Jun 20239368
Jul 202383815
Aug 202312715
Sep 20234278
Oct 202373914
Nov 202385421
Dec 2023510619
Jan 20244218
Feb 202453112
Mar 202442421
Apr 202463424
May 202442114
Jun 202433515
Jul 202474217
Aug 20241155
Sep 202433112
Oct 202443812
Nov 202462910
Dec 202423614
Jan 202552910
Feb 2025164511
Mar 202563315
Apr 202512713
May 202524016
Jun 2025194019
Jul 202585422
Aug 2025105222
Sep 2025215613
Oct 2025218519
Nov 20251914219
Dec 20253716528

Statistics from Altmetric.com

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 43, Issue 3
1 Mar 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study
Konstantinos Tselios, Dafna D. Gladman, Jiandong Su, Murray B. Urowitz
The Journal of Rheumatology Mar 2016, 43 (3) 552-558; DOI: 10.3899/jrheum.150779

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study
Konstantinos Tselios, Dafna D. Gladman, Jiandong Su, Murray B. Urowitz
The Journal of Rheumatology Mar 2016, 43 (3) 552-558; DOI: 10.3899/jrheum.150779
del.icio.us logo Twitter logo Facebook logo  logo Mendeley logo
  • Tweet Widget
  •  logo
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • References
  • PDF

Keywords

MYCOPHENOLATE MOFETIL
SYSTEMIC LUPUS ERYTHEMATOSUS
NONRENAL MANIFESTATIONS

Related Articles

Cited By...

More in this TOC Section

  • Congruence Between Child Self-Reported and Caregiver-Proxy–Reported Health-Related Quality of Life in Children With Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus
  • A Global Survey of Quinacrine Use in Systemic and Cutaneous Lupus Erythematosus
  • Comorbidity Development and Mortality During 10 Years of Follow-up in a Danish Nationwide Cohort of 3178 Patients With Systemic Lupus Erythematosus
Show more Article

Similar Articles

Keywords

  • MYCOPHENOLATE MOFETIL
  • systemic lupus erythematosus
  • NONRENAL MANIFESTATIONS

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2025 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire